<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HA5B77DBCB1754B0B9335280FBB4F7ACB" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 204 IH: Genetically Engineered Salmon Labeling Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-01-03</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 204</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170103">January 3, 2017</action-date><action-desc><sponsor name-id="Y000033">Mr. Young of Alaska</sponsor> (for himself and <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the market name of genetically altered salmon in the United States, and for other
			 purposes.</official-title></form>
	<legis-body id="H7E3D37F0DC4548BBBF478E92152CA10D" style="OLC">
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
 title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Genetically Engineered Salmon Labeling Act</short-title></quote>.</text> </section><section id="id4A354D142146461BAF88EC446EF45565"><enum>2.</enum><header>Purposes</header><text display-inline="no-display-inline">It is the purpose of this Act to—</text>
 <paragraph id="id6D60A1016244470A8E1DF17B9F977AED"><enum>(1)</enum><text display-inline="yes-display-inline">ensure that consumers in the United States can make informed decisions when purchasing salmon; and</text> </paragraph><paragraph id="id47D19D7AA0414E7F80863539A409EFF8"><enum>(2)</enum><text>authorize an independent scientific review of—</text>
 <subparagraph id="idEF005F2908CF44F8B5FA9C05A0F75C1B"><enum>(A)</enum><text>the possible effects of genetically engineered salmon on wild salmon stocks; and</text> </subparagraph><subparagraph id="id3864BD815226432095D48B9B84BCC740"><enum>(B)</enum><text>the Food and Drug Administration’s approval of genetically engineered salmon for human consumption.</text>
				</subparagraph></paragraph></section><section id="idFF2FE02733A64958AAF1FA725BD52768"><enum>3.</enum><header>Market name for genetically engineered salmon</header>
 <subsection id="id9126B0E3C1BC4BC6A31A2F34127EAEFC"><enum>(a)</enum><header>In General</header><text>Notwithstanding any other provision of law, for purposes of applying the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>), the acceptable market name of any salmon that is genetically engineered shall include the words “Genetically Engineered” or <quote>GE</quote> prior to the existing acceptable market name.</text>
 </subsection><subsection id="id0AD0AF43A67441DCBA5B3FF6EFE47ABC"><enum>(b)</enum><header>Definition</header><text>For purposes of this section, salmon is genetically engineered if it has been modified by recombinant DNA (rDNA) techniques, including the entire lineage of salmon that contain the rDNA modification.</text>
			</subsection></section><section id="id68A960E72037461AAC3EFF8BB304C08F"><enum>4.</enum><header>Third-party review of certain salmon approval</header>
 <text display-inline="no-display-inline">The Secretary of Health and Human Services shall ensure that an independent scientific organization conducts a review of the environmental assessment that was carried out by the Food and Drug Administration in support of an approval of a new animal drug application related to AquAdvantage Salmon, dated November 12, 2015.</text>
		</section></legis-body></bill>


